Trials / Completed
CompletedNCT03036241
Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis (Dialysis Fistulae)
Drug-eluting Balloon vs. Conventional Balloon in the Treatment of (re)Stenosis - a Randomized Prospective Study (Dialysis Fistulae)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Helsinki University Central Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the use of drug-eluting balloons is effective in the treatment of (re)stenosis in dialysis fistulae.
Detailed description
Drug-eluting devices have proved beneficial in the treatment of stenosis in native coronary and lower limb arteries. Stenosis and restenosis is a known problem in dialysis fistulae and drug-eluting devices might be beneficial in this field as well. In the procedure a conventional balloon is passed through the stenosis which is then dilated. After this patients are randomized before a second dilatation with either a conventional balloon or a drug-coated balloon. The stenosis is evaluated preoperatively and followed up by means of ultrasound by a vascular technician. Follow-up will end at 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Conventional angioplasty | Angioplasty with conventional balloon |
| DEVICE | Angioplasty with drug-eluting balloon | Angioplasty with drug-eluting balloon |
Timeline
- Start date
- 2013-01-23
- Primary completion
- 2017-02-28
- Completion
- 2017-02-28
- First posted
- 2017-01-30
- Last updated
- 2017-06-23
Source: ClinicalTrials.gov record NCT03036241. Inclusion in this directory is not an endorsement.